Zynerba Pharmaceuticals, Inc. 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Aug 6, 2015
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Award
Stock Option
2015-08-04+46,616→ 46,616 totalExercise: $14.00Exp: 2025-08-04→ Common Stock (46,616 underlying)
Footnotes (1)
- [F1]The stock option vests in sixteen equal quarterly installments beginning on November 4, 2015.